Taro Pharmaceutical Industries Ltd. TAL.F Stock
Taro Pharmaceutical Industries Ltd. Price Chart
Taro Pharmaceutical Industries Ltd. TAL.F Financial and Trading Overview
Taro Pharmaceutical Industries Ltd. stock price | 39.2 EUR |
Previous Close | 37.6 EUR |
Open | 37.2 EUR |
Bid | 37.2 EUR x 20000 |
Ask | 37.6 EUR x 20000 |
Day's Range | 37.2 - 37.2 EUR |
52 Week Range | 21 - 39 EUR |
Volume | 5 EUR |
Avg. Volume | 0 EUR |
Market Cap | 1.4B EUR |
Beta (5Y Monthly) | 0.675 |
PE Ratio (TTM) | 56.363636 |
EPS (TTM) | 1.14 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | December 10, 2018 |
1y Target Est | 82 EUR |
TAL.F Valuation Measures
Enterprise Value | 570.42M EUR |
Trailing P/E | 56.363636 |
Forward P/E | 8.175824 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.4473612 |
Price/Book (mrq) | 0.80778253 |
Enterprise Value/Revenue | 0.996 |
Enterprise Value/EBITDA | 11.445 |
Trading Information
Taro Pharmaceutical Industries Ltd. Stock Price History
Beta (5Y Monthly) | 0.675 |
52-Week Change | 12.50% |
S&P500 52-Week Change | 20.43% |
52 Week High | 39 EUR |
52 Week Low | 21 EUR |
50-Day Moving Average | 26.17 EUR |
200-Day Moving Average | 28.25 EUR |
TAL.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 37.58M |
Float | 8.09M |
Short Ratio | N/A |
% Held by Insiders | 78.48% |
% Held by Institutions | 12.58% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 4.44% |
Operating Margin (ttm) | 3.09% |
Gross Margin | 46.83% |
EBITDA Margin | 8.69% |
Management Effectiveness
Return on Assets (ttm) | 0.51% |
Return on Equity (ttm) | 1.47% |
Income Statement
Revenue (ttm) | 572.95M EUR |
Revenue Per Share (ttm) | 15.24 EUR |
Quarterly Revenue Growth (yoy) | 2.29% |
Gross Profit (ttm) | N/A |
EBITDA | 49.84M EUR |
Net Income Avi to Common (ttm) | 25.45M EUR |
Diluted EPS (ttm) | 0.66 |
Quarterly Earnings Growth (yoy) | -74.79% |
Balance Sheet
Total Cash (mrq) | 850.29M EUR |
Total Cash Per Share (mrq) | 22.62 EUR |
Total Debt (mrq) | 0 EUR |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 3.466 |
Book Value Per Share (mrq) | 46.052 |
Cash Flow Statement
Operating Cash Flow (ttm) | 31.75M EUR |
Levered Free Cash Flow (ttm) | 11.99M EUR |
Profile of Taro Pharmaceutical Industries Ltd.
Country | Germany |
State | N/A |
City | Haifa |
Address | 14 Hakitor Street |
ZIP | 2624761 |
Phone | 972 4 847 5700 |
Website | https://www.taro.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1950 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
Q&A For Taro Pharmaceutical Industries Ltd. Stock
What is a current TAL.F stock price?
Taro Pharmaceutical Industries Ltd. TAL.F stock price today per share is 39.2 EUR.
How to purchase Taro Pharmaceutical Industries Ltd. stock?
You can buy TAL.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Taro Pharmaceutical Industries Ltd.?
The stock symbol or ticker of Taro Pharmaceutical Industries Ltd. is TAL.F.
Which industry does the Taro Pharmaceutical Industries Ltd. company belong to?
The Taro Pharmaceutical Industries Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Taro Pharmaceutical Industries Ltd. have in circulation?
The max supply of Taro Pharmaceutical Industries Ltd. shares is 37.58M.
What is Taro Pharmaceutical Industries Ltd. Price to Earnings Ratio (PE Ratio)?
Taro Pharmaceutical Industries Ltd. PE Ratio is 34.38596700 now.
What was Taro Pharmaceutical Industries Ltd. earnings per share over the trailing 12 months (TTM)?
Taro Pharmaceutical Industries Ltd. EPS is 1.14 EUR over the trailing 12 months.
Which sector does the Taro Pharmaceutical Industries Ltd. company belong to?
The Taro Pharmaceutical Industries Ltd. sector is Healthcare.